KBTBD6 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 8.88740000037913E-07 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
3.31320000002133E-06 |
Normal-vs-Stage2 |
6.757800E-02 |
Normal-vs-Stage3 |
7.159900E-04 |
Normal-vs-Stage4 |
2.476400E-01 |
Stage1-vs-Stage2 |
5.547400E-01 |
Stage1-vs-Stage3 |
6.667400E-01 |
Stage1-vs-Stage4 |
3.747400E-01 |
Stage2-vs-Stage3 |
4.173000E-01 |
Stage2-vs-Stage4 |
7.129800E-01 |
Stage3-vs-Stage4 |
2.558000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
1.7745000000513E-06 |
Normal-vs-AfricanAmerican |
2.611300E-04 |
Normal-vs-Asian |
2.283100E-03 |
Caucasian-vs-AfricanAmerican |
9.924200E-01 |
Caucasian-vs-Asian |
3.896400E-01 |
AfricanAmerican-vs-Asian |
4.428600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
1.5239999995309E-07 |
Normal-vs-Female |
8.777000E-03 |
Male-vs-Female |
5.635700E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
Descriptions |
Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Normal_Weight |
2.116300E-03 |
Normal-vs-Extreme_Weight |
2.6921999995988E-07 |
Normal-vs-Obese |
2.811600E-04 |
Normal-vs-Extreme_Obese |
9.204800E-01 |
Normal_Weight-vs-Extreme_Weight |
3.284400E-01 |
Normal_Weight-vs-Obese |
8.371400E-01 |
Normal_Weight-vs-Extreme_Obese |
1.676950E-01 |
Extreme_Weight-vs-Obese |
1.554380E-01 |
Extreme_Weight-vs-Extreme_Obese |
1.503620E-01 |
Obese-vs-Extreme_Obese |
3.033800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
1.282410E-03 |
Normal-vs-Age(41-60Yrs) |
4.718400E-03 |
Normal-vs-Age(61-80Yrs) |
1.33630000398455E-08 |
Normal-vs-Age(81-100Yrs) |
1.936240E-02 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.088200E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.418800E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.880400E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.720650E-03 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.265180E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.649400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-VS-Type1 PRCC |
4.01269999994458E-06 |
Normal-VS-Type2 PRCC |
1.89036999999059E-05 |
Normal-VS-KIRP CIMP |
4.01140000000355E-05 |
Normal-VS-Unclassified PRCC |
2.776300E-02 |
Type1 PRCC-VS-Type2 PRCC |
2.936800E-01 |
Type1 PRCC-VS-KIRP CIMP |
1.614200E-01 |
Type1 PRCC-VS-Unclassified PRCC |
5.291800E-01 |
Type2 PRCC-VS-KIRP CIMP |
4.943600E-01 |
Type2 PRCC-VS-Unclassified PRCC |
2.437800E-01 |
KIRP CIMP-VS-Unclassified PRCC |
1.648630E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
7.18410000044578E-07 |
Normal-vs-N1 |
3.140300E-02 |
Normal-vs-N2 |
8.15929999999909E-05 |
N0-vs-N1 |
2.372600E-01 |
N0-vs-N2 |
2.111600E-01 |
N1-vs-N2 |
1.546360E-01 |
|
|